Is Radiotherapy Adequate Treatment for Patients not in Complete Metabolic Response after First-Line Chemotherapy for DLBCL?

被引：0
|
作者：
Brady, J. L. [1 ]
Mikhaeel, G. [2 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust London, London, England
[2] Kings Coll London, Canc Div, London, England
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.518
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
139
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
  • [41] Impact of thoracic radiotherapy on first-line treatment outcomes in ES-SCLC patients
    Mu, Xiaoli
    Zhou, Yixin
    Liu, Qing
    Wang, Jiantao
    Xu, Feng
    Luo, Feng
    Wang, Ke
    Li, Lu
    Tian, Panwen
    Li, Yalun
    Liu, Jiewei
    Zhang, Yan
    Liu, Jiyan
    Li, Yan
    CANCER MEDICINE, 2024, 13 (17):
  • [42] Impact of Thoracic Radiotherapy on First-Line Treatment Outcomes in ES-SCLC Patients
    Xiaoli, M.
    Yan, L.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S678 - S678
  • [43] CAPECITABINE TREATMENT IN PATIENTS WITH ADVANCED/METASTATIC COLORECTAL CARCINOMA AFTER ANY CHEMOTHERAPY LINE FAILURE OR DURING FIRST-LINE TREATMENT IN PATIENTS WHERE POLYCHEMOTHERAPY IS NOT FEASIBLE
    Losa, F.
    Pericay, C.
    Perez de Olaguer, J.
    Dotor, E.
    Pisa, A.
    Saigi, E.
    Casado, E.
    Roca, J.
    Alfaro, J.
    Batiste-Alentorn, E.
    ANNALS OF ONCOLOGY, 2009, 20 : 65 - 65
  • [44] Impact of Clinical Response to First-Line Chemotherapy on Gastric Cancer Patients Treated with Second-Line and Third-Line Chemotherapy
    Kodera, Yasuhiro
    Ito, Yuichi
    Ohashi, Norifumi
    Nakayama, Goro
    Koike, Masahiko
    Fujiwara, Michitaka
    Nakao, Akimasa
    HEPATO-GASTROENTEROLOGY, 2011, 58 (107) : 1041 - 1045
  • [45] Cyberknife stereotactic radiotherapy as the first-line treatment of intracranial meningiomas
    Manabe, Y.
    Iwata, H.
    Ogino, H.
    Murai, T.
    Iwabuchi, M.
    Tamura, T.
    Mori, Y.
    Suzuki, H.
    Shibamoto, Y.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S1 - S2
  • [46] Potential Treatment Options After First-Line Chemotherapy for Advanced NSCLC: Maintenance Treatment or Early Second-Line?
    Gridelli, Cesare
    Maione, Paolo
    Rossi, Antonio
    Ferrara, Marianna Luciana
    Bareschino, Maria Anna
    Schettino, Clorinda
    Sacco, Paola Claudia
    Ciardiello, Fortunato
    ONCOLOGIST, 2009, 14 (02): : 137 - 147
  • [47] End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA
    Kostakoglu, Lale
    Martelli, Maurizio
    Sehn, Laurie H.
    Belada, David
    Carella, Angelo-Michele
    Chua, Neil
    Gonzalez-Barca, Eva
    Hong, Xiaonan
    Pinto, Antonio
    Shi, Yuankai
    Tatsumi, Yoichi
    Knapp, Andrea
    Mattiello, Federico
    Nielsen, Tina
    Sahin, Deniz
    Sellam, Gila
    Oestergaard, Mikkel Z.
    Vitolo, Umberto
    Trneny, Marek
    BLOOD ADVANCES, 2021, 5 (05) : 1283 - 1290
  • [48] Efficacy of Chemotherapy after First-Line Gefitinib for EGFR-Mutant NSCLC Patients
    Kuwako, Tomohito
    Imai, Hisao
    Masuda, Tomomi
    Miura, Yosuke
    Yoshino, Reiko
    Kaira, Kyoichi
    Shimizu, Kimihiro
    Sunaga, Noriaki
    Tomizawa, Yoshio
    Ishihara, Shinichi
    Mogi, Akira
    Hisada, Takeshi
    Minato, Koichi
    Takise, Atsushi
    Saito, Ryusei
    Yamada, Masanobu
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S646 - S646
  • [49] Capecitabine Maintenance Therapy after First-Line Chemotherapy in Patients with Metastatic Colorectal Cancer
    Yan Li
    Department of GI Oncology
    Chinese Journal of Cancer Research, 2010, 22 (03) : 181 - 185
  • [50] Capecitabine Maintenance Therapy after First-Line Chemotherapy in Patients with Metastatic Colorectal Cancer
    Li, Yan
    Li, Jing
    Lu, Ming
    Wang, Xi-cheng
    Shen, Lin
    CHINESE JOURNAL OF CANCER RESEARCH, 2010, 22 (03) : 181 - 185
12345